摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-dichloro-5-[5-(4-chlorophenyl)-1,2,4-triazol-3-yl]benzenesulfonamide | 1617508-83-4

中文名称
——
中文别名
——
英文名称
2,4-dichloro-5-[5-(4-chlorophenyl)-1,2,4-triazol-3-yl]benzenesulfonamide
英文别名
2,4-dichloro-5-[3-(4-chlorophenyl)-1H-1,2,4-triazol-5-yl]benzenesulfonamide
2,4-dichloro-5-[5-(4-chlorophenyl)-1,2,4-triazol-3-yl]benzenesulfonamide化学式
CAS
1617508-83-4
化学式
C14H9Cl3N4O2S
mdl
——
分子量
403.676
InChiKey
AYFNVXHJZPBGPG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    288-290 °C
  • 沸点:
    663.877±65.00 °C(Press: 760.00 Torr)(predicted)
  • 密度:
    1.617±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    110
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为产物:
    参考文献:
    名称:
    Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII
    摘要:
    A series of novel 5-substituted 2,4-dichlorobenzenesulfonamides 5a-c, 6a-d, 7a-j and 10a-i have been synthesized and investigated as inhibitors of four isoforms of zinc enzyme carbonic anhydrase (CA.EC 4.2.1.1), that is the cytosolic CA I and II, and tumor-associated isozymes CA IX and XII. Against the human CA I investigated compounds displayed K-I values from 349 to 7355 nM, toward hCA II at range of 6.9 to 164 nM, while against hCA IX ranging from 2.8 to 76 nM and against hCA XII in the range of 2.7 to 95 nM. The excellent inhibitory activity against tumor-associated hCA IX was found. The twenty one new compounds displayed a powerful inhibitory potency toward hCA IX (K-I = 2.8-21.7 nM) in comparison with the clinically used CAIs AAZ, MZA, EZA, DCP and IND (24-50 nM). Among them the most potent hCA IX inhibitor 7b (K-I = 2.8 nM) was 8.5-fold stronger than IND (K-I = 24 nM). Toward tumor-associated hCA XII compounds 6c and 10a (K-I = 2.7 and 2.8 nM, respectively) showed a better inhibitory potency than reference sulfonamides MZA and IND (K-I = 3.4 nM). (C) 2014 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2014.05.039
点击查看最新优质反应信息